Factors modifying the association between hormone-replacement therapy and breast cancer risk

European Journal of Epidemiology

Volumn 20, Issue 8, 2005, Pages 699-711

  Pesch, Beate ^a,f   Ko, Yon ^b   Brauch, Hiltrud ^c   Hamann, Ute ^d   Harth, Volker ^a   Rabstein, Sylvia ^a   Pierl, Christiane ^a   Fischer, Hans Peter ^e   Baisch, Christian ^c,d   Justenhoven, Christina ^c   Ranft, Ulrich ^f   Brüning, Thomas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Johanniter Krankenhaus   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

Breast cancer risks; Case control study; Family history of cancer; Hormone replacement therapy; Mammography; Risk modifying factors

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; RISK ASSESSMENT; RISK REDUCTION;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 24644524997     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-005-0032-0     Document Type: Article

References (36)

1. Million Women Study Collaborators 2002 Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000 BJOG 109 12 1319 1330
2. HD Nelson LL Humphrey P Nygren SM Teutsch JD Allan 2002 Postmenopausal hormone replacement therapy: scientific review JAMA 288 7 872 881
3. Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 9084 1047 1059
4. E Fernandez S Gallus C Bosetti S Franceschi E Negri C La Vecchia 2003 Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies Int J Cancer 105 3 408 412
5. JE Rossouw GL Anderson RL Prentice 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 321 333
6. V Beral 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 419 427
7. E Banks I Barnes K Baker TJ Key 2002 Use of hormonal therapy for menopause in nine European countries IARC Sci Publ 156 301 303
8. E Greiser 2001 Hormone replacement therapy-treatment with risk factors Dtsch Med Wochenschr 126 9 255 256
9. Arzneimittelkommission der deutschen Aerzteschaft. [Hormone replacement therapy]. Arzneiverordnung in der Praxis-Sonderheft 2003 [in German] 2003
10. J Randal 2003 NIH workshop tries to create consensus on HRT use J Natl Cancer Inst 95 1 9 11
11. R Holle B Gieseke H Nagl 2000 PC-gestuetzte Datenerhebung als Beitrag zur Qualitaetssicherung in Gesundheitssurveys: Erfahrungen mit DAIMON im KORA-Survey 2000 Zeitschrift fuer Gesundheitswissenschaften 8 165 173
12. WHO. WHO Scientific Group on Research on the Menopause in the 1990's. Geneva. Switzerland. WHO Technical Report Series 866, 1994
13. SAS 2000 Changes and Enhancement Through Release 8.0 SAS Institute SAS/STAT Software Cary, NC, USA
14. W Braendle J Semler 2000 Postmenopausal hormone replacement under scrutiny. "Fatal therapy"? MMW Fortschr Med 142 33-34 11 12
15. G Ursin CC Tseng A Paganini-Hill 2002 Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20 3 699 706
16. A Tavani C Braga C La Vecchia E Negri A Russo S Franceschi 1997 Attributable risks for breast cancer in Italy: Education, family history and reproductive and hormonal factors Int J Cancer 70 2 159 163
17. N Biglia M Cozzarella R Ponzone 2004 Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy Gynecol Endocrinol 18 3 165 174
18. HL Olsson C Ingvar A Bladstrom 2003 Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden Cancer 97 6 1387 1392
19. KK Steinberg SB Thacker SJ Smith 1991 A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer JAMA 265 15 1985 1990
20. H Olsson A Bladstrom C Ingvar TR Moller 2001 A population-based cohort study of HRT use and breast cancer in southern Sweden Br J Cancer 85 5 674 677
21. E Banks V Beral R Cameron 2002 Comparison of various characteristics of women who do and do not attend for breast cancer screening Breast Cancer Res 4 1 R1
22. PA Carney DL Miglioretti BC Yankaskas 2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography Ann Intern Med 138 3 168 175
23. RT Chlebowski SL Hendrix RD Langer 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial JAMA 289 24 3243 3253
24. LJ Hofseth AM Raafat JR Osuch DR Pathak CA Slomski SZ Haslam 1999 Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J Clin Endocrinol Metab 84 12 4559 4565
25. I Persson E Thurfjell L Holmberg 1997 Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density J Clin Oncol 15 10 3201 3207
26. CM Rutter MT Mandelson MB Laya DJ Seger S Taplin 2001 Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy JAMA 285 2 171 176
27. MR Andersen R Smith H Meischke D Bowen N Urban 2003 Breast cancer worry and mammography use by women with and without a family history in a population-based sample Cancer Epidemiol Biomarkers Prev 12 4 314 320
28. C Lerman M Daly C Sands 1993 Mammography adherence and psychological distress among women at risk for breast cancer J Natl Cancer Inst 85 13 1074 1080
29. AM Raafat LJ Hofseth SZ Haslam 2001 Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model Am J Obstet Gynecol 184 3 340 349
30. CL Chen NS Weiss P Newcomb W Barlow E White 2002 Hormone replacement therapy in relation to breast cancer JAMA 287 6 734 741
31. C Magnusson JA Baron N Correia R Bergstrom HO Adami I Persson 1999 Breast-cancer risk following long-term oestrogen- and oestrogen-progestin- replacement therapy Int J Cancer 81 3 339 344
32. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover 2000 Menopausal estrogen and estrogen- progestin replacement therapy and breast cancer risk JAMA 283 4 485 491
33. LB Jensen P Vestergaard AP Hermann 2003 Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: A randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study J Bone Miner Res 18 2 333 342
34. SA Norman JA Berlin AL Weber 2003 Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women Cancer Causes Control 14 10 933 943
35. CW Daniel GB Silberstein P Strickland 1987 Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography Cancer Res 47 22 6052 6057
36. DJ Hunter JE Manson GA Colditz 1997 Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women Contraception 56 6 373 378